Molecular Targets of Synaptic Dysfunction in AD

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004004
Summary
A significant amount of early memory deficit in Alzheimer’s disease (AD) is caused by abnormal communication between nerve cells in the hippocampus, a brain region dedicated to memory formation. Such communication occurs at excitatory synapses, specialized cell-cell contact sites where the neurotransmitter glutamate is released and detected. A prominent form of AD-associated synapse dysfunction is the impairment of synaptic plasticity by beta-amyloid (Aß), the protein fragment that accumulates in the brains of Alzheimer’s patients. A newly recognized mechanism for changing synaptic strength is the removal of neurotransmitter receptors that detect the neurotransmitter glutamate by a process called endocytosis. Dr. Ehlers has found that Aß peptides cause a selective activation of endocytosis molecules with a simultaneous loss of glutamate receptors at hippocampal synapses. Using his preliminary data, Dr. Ehlers is working to define the underlying cellular mechanism of the Aß-dependent disturbance of endocytosis and to identify molecular signals that restore normal synapse function in the amyloid-exposed brain.
Related Grants
Alzheimer's Disease Research
Repairing the Body Clock to Delay Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Jae-eun Miller, PhD
Current Organization
Columbia University
Repairing the Body Clock to Delay Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Jae-eun Miller, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting the Adaptive Immunity to Prevent Alzheimer's Brain Degeneration
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Joshua Emmerson, PhD
Current Organization
Washington University in St.Louis
Targeting the Adaptive Immunity to Prevent Alzheimer's Brain Degeneration
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Joshua Emmerson, PhD
Current Organization
Washington University in St.Louis
Alzheimer's Disease Research
Ultrasound Treatment to Replenish Cells Essential for Brain Function
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Isabelle Aubert, PhD
Current Organization
Sunnybrook Research Institute
Ultrasound Treatment to Replenish Cells Essential for Brain Function
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Isabelle Aubert, PhD
Current Organization
Sunnybrook Research Institute